AIM ImmunoTech
33 hedge funds and large institutions have $1.86M invested in AIM ImmunoTech in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
3% less funds holding
Funds holding: 34 → 33 (-1)
5% less capital invested
Capital invested by funds: $1.97M → $1.86M (-$106K)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$15.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.39K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.09K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$6.57K |
| 5 |
Renaissance Technologies
New York
|
+$4.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$45.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$27.6K |
| 3 |
VF
Virtu Financial
New York
|
-$6.29K |
| 4 |
HF
HRT Financial
New York
|
-$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
26
Hoey Investments
Coatesville,
Pennsylvania
| $440 | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $328 | – | – | – |
|
|
AF
28
Advisornet Financial
Minnetonka,
Minnesota
| $220 | – | – | – |
|
|
TWC
29
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $107 | – | – | – |
|
30
JP Morgan Chase
New York
| $38 | – | – | – |
|
31
Bank of America
Charlotte,
North Carolina
| $26 | +$47 | +1 | New |
|
|
HNB
32
Huntington National Bank
Columbus,
Ohio
| $25 | – | – | – |
|
33
Fidelity Investments
Boston,
Massachusetts
| $2 | – | – | – |
|
34
BNP Paribas Financial Markets
Paris,
France
| $1 | – | – | – |
|
35
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1 | – | – | – |
|
|
TSS
36
Two Sigma Securities
New York
| – | -$27.6K | -607 | Closed |
|
|
HF
37
HRT Financial
New York
| – | -$4K | -108 | Closed |
|
|
VAG
38
VisionPoint Advisory Group
Dallas,
Texas
| – | -$1.43K | -31 | Closed |
|
|
IWP
39
IAG Wealth Partners
Waukesha,
Wisconsin
| – | -$218 | -5 | Closed |
|
40
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$47 | -1 | -33% |
|
AIM Hedge Fund Activity: Q4 2023 in Review
33 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2023, worth a combined $1.86M — down 5.4% from $1.97M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AIM and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $15.9K. The largest seller was Morgan Stanley, cutting an estimated $45.6K.
- 33 institutional investors held AIM ImmunoTech (AIM) as of Q4 2023, down from 34 in Q3 2023.
- Funds reported $1.86M of AIM ImmunoTech stock for Q4 2023, down 5.4% quarter-over-quarter.
- 3 funds opened new AIM ImmunoTech positions in Q4 2023 and 4 closed out, a net change of -1 holder.
- The largest AIM ImmunoTech buyer in Q4 2023 was Citadel Advisors, an estimated $15.9K added.
- The largest AIM ImmunoTech seller in Q4 2023 was Morgan Stanley, an estimated $45.6K sold.
Based on aggregated 13F filings for Q4 2023.